FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
1,063 letters match. Newest first.
-
DrugsAnuMed International, LLC
FDA warned AnuMed International about unapproved drugs, misleading FDA claims, and manufacturing quality failures.
High risk -
FoodAnglo Freight USA Inc.
Illinois food importer Anglo Freight USA lacked FSVP records for flour, kumis, seabuckthorn juice and teas, and never registered its facility.
Medium -
DrugsCARsgen Therapeutics Corporation
FDA warns CARsgen over CGMP violations for investigational CAR T cell products at Durham facility.
High risk -
FoodMinland of Texas, Inc.
FDA warned Minland of Texas that it lacked a required Foreign Supplier Verification Program for imported peanut gluten, soy sauce, and rice vinegar.
Medium -
BiologicsBerkeley Biologics, LLC, previously operating as Elutia, Inc. – Orthobiologics Business Unit, formerly Aziyo Biologics, Inc.
FDA says Berkeley Biologics' viable bone matrix products are unapproved drugs, with donor screening failures tied to tuberculosis infections.
High risk -
DrugsEugia Pharma Specialities Limited
FDA cited Eugia Pharma Specialities for CGMP violations at its India sterile injectable plant, including falsified records and contamination risks.
High risk -
DrugsIntercos Europe S.p.A
FDA warned Intercos Europe S.p.A over current good manufacturing practice violations in OTC sunscreen drugs, including missing glycerin DEG/EG testing and poor investigations.
High risk -
FoodAUSTROFOOD S.A.S.
Austrofood's apple cinnamon puree pouches were adulterated with extremely high lead from cinnamon; hazard controls failed.
High risk -
DrugsNowrez & Ismail Shukri Company
FDA warns Jordanian OTC drug maker Nowrez & Ismail Shukri over CGMP violations and import alert.
High risk -
DrugsCentral Admixture Pharmacy Services, Inc.
FDA warns Central Admixture Pharmacy Services over sterile compounded drugs, contamination risks, and quality failures at its San Diego site.
High risk -
DrugsGuangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd.
FDA warned Guangzhou Baiyunshan Jingxiutang Pharmaceutical over current good manufacturing practice violations in over-the-counter drug manufacturing, including inadequate specs and microbial testing.
High risk -
DrugsOmega Tech Labs LLC
Omega Tech Labs in Boise, Idaho, released microbially contaminated combination drug-device product and failed manufacturing rules.
High risk -
DrugsVelocity Pharma LLC
Velocity Pharma distributed eye drop drugs made by contract manufacturers with serious manufacturing and sanitation violations.
High risk -
OtherCorporacion Avicola Morovis Inc
FDA warns Corporacion Avicola Morovis over Salmonella prevention failures at its Puerto Rico shell egg farm.
High risk -
DrugsBrassica Pharma Pvt. Ltd.
FDA warns Brassica Pharma over fabricated sterility and environmental data and poor aseptic controls for sterile drugs.
High risk -
FoodFormulation Technology, Inc.
FDA warns Formulation Technology over unapproved migraine supplement claims and manufacturing/labeling violations.
High risk -
DrugsGenuine Virgin Aloe Corp dba Triderma
FDA warned Triderma, an Anaheim OTC skin cream maker, of CGMP violations after a January 2024 inspection.
High risk -
FoodKey Foods Co. dba Key Food Services
FDA warned Key Foods Co. dba Key Food Services that it lacked required Foreign Supplier Verification Program plans for several imported foods.
Medium -
DrugsARG Laboratories, Inc.
FDA found ARG Laboratories released failing over-the-counter drug lots, lacked manufacturing controls, and marketed two unapproved pain creams.
High risk -
DrugsArt of Beauty Company, Inc.
FDA warned Art of Beauty over manufacturing-rule violations in OTC hand sanitizer, including missing component and finished-product testing.
High risk -
FoodNatural Ginger, Corp/Jonaus Corp
FDA warned Natural Ginger that it markets six syrups and supplements as unapproved new drugs with disease-treatment claims on its website.
Medium -
DrugsOptikem International Inc.
FDA warns Optikem International after inspection found inadequate aseptic controls for sterile ophthalmic drugs, including contamination and validation failures.
High risk -
DrugsLaboratorio Magnachem International
FDA cited Laboratorio Magnachem for CGMP failures and unapproved, misbranded Broncochem cough/cold drugs after a 2023 inspection.
High risk -
FoodPepsiCo, Inc.
FDA warned PepsiCo after Salmonella Cubana was found at its Danville, Illinois Quaker Oats plant, prompting recalls of granola bars and cereals.
High risk -
DrugsSun Pharmaceutical Industries Limited
FDA cited Sun Pharmaceutical Industries for inadequate cleaning and maintenance at its Dadra drug plant, risking cross-contamination, and for weak investigations.
High risk -
FoodFrozen Food Development, Inc.
Frozen Food Development packed ready-to-eat frozen produce under rodent activity and lacked required pathogen controls.
High risk -
DrugsGFA Production Xiamen Co., Ltd.
GFA Production Xiamen failed CGMP for drugs, including process validation, cleaning, and lab controls.
High risk -
DrugsLandy International
FDA found Landy International’s OTC hand sanitizers adulterated after a 2023 inspection revealed missing testing, unsafe water, and data integrity failures.
High risk -
DrugsAqualex Co., Ltd.
Aqualex, a Korean contract manufacturer, was cited for manufacturing failures and an unapproved OTC sunscreen with misleading labeling.
High risk -
FoodDollar Tree Inc.
Dollar Tree continued offering recalled WanaBana apple cinnamon puree pouches with extremely high lead levels, FDA says.
High risk -
BiologicsNeobiosis, LLC
FDA warns Neobiosis over unapproved amniotic fluid and umbilical cord products and serious manufacturing quality failures.
High risk -
DrugsTCT Nutraceuticals SDN. BHD
FDA warns TCT Nutraceuticals over manufacturing-rule failures in OTC hand sanitizer, including no methanol testing.
High risk -
DrugsCosmetic Solutions, LLC
FDA warns Cosmetic Solutions over manufacturing failures and unapproved OTC drugs at Boca Raton plant.
High risk -
AnimalAll Things Bunnies, Inc.
All Things Bunnies markets Toltrazuril 5% Suspension as an unapproved new animal drug for coccidiosis.
Medium -
FoodBaja Best Distributing, Inc.
Baja Best Distributing lacked required FSVP for imported fresh cucumbers and strawberries from Mexico, FDA says.
Medium -
DevicesTechlem Medical Corporation
Techlem Medical Corporation failed quality and unique device identifier requirements for wheeled stretchers, FDA says.
Medium -
FoodGenpro Imports & Export Inc.
FDA warns Genpro Imports over missing FSVP records for imported produce and ginger.
Medium -
DrugsAruba Aloe Balm N.V.
Aruba Aloe Balm N.V. made OTC drugs with methanol-contaminated ethanol and failed CGMP, prompting recall and import alert.
High risk -
DrugsBiomic Sciences, LLC dba ION Intelligence of Nature
Biomic Sciences' nasal spray was grossly contaminated with microorganisms, and FDA also found manufacturing and labeling violations.
High risk -
FoodAmin Trading Agency LLC
FDA found Amin Trading Agency lacked required foreign supplier checks for imported Indian spice products, including Everest and Masala E Magic.
Medium -
FoodRash Catering Services, LLC
FDA warns Houston importer Rash Catering for having no FSVP for its imported flours and biscuits.
Medium -
DrugsSeatex, LLC
FDA: Seatex made hand sanitizer on equipment also used for floor cleaner and skipped ingredient identity tests.
High risk -
DrugsCentral Admixture Pharmacy Services, Inc.
FDA warned sterile drug compounder Central Admixture Pharmacy Services (Phoenix) that dirty areas and weak sterility testing made its drugs adulterated.
High risk -
FoodMeditco, Inc. D.B.A. Phoenicia Specialty Foods
FDA says Meditco, a Houston food importer, lacked FSVP records for chickpeas, falafel spices, and rose syrup.
Medium -
FoodOcean Group Inc.
Ocean Group Inc.'s ready-to-eat salmon and tuna were tied to Listeria monocytogenes and insanitary conditions after an FDA inspection.
High risk -
DrugsWestwood Laboratories LLC
FDA warned Westwood Laboratories after an inspection found inadequate investigations, raw material testing, lab controls, and water/cleaning controls for OTC drugs.
High risk -
DrugsCohere Beauty
FDA cites Cohere Beauty for unvalidated OTC drug manufacturing and inadequate quality oversight at its Santa Fe Springs facility.
Medium -
FoodHacienda Mexican Foods, LLC
FDA warns Hacienda Mexican Foods of Salmonella risk and missing controls in ready-to-eat tortillas.
High risk -
DrugsSeatex, LLC
Seatex, LLC made OTC hand sanitizer drugs with inadequate current good manufacturing practice (CGMP), including shared equipment with industrial chemicals and missing component testing.
High risk -
DrugsCentral Admixture Pharmacy Services, Inc.
FDA warned Central Admixture Pharmacy Services' Allentown outsourcing facility over sterile drug contamination and CGMP failures.
High risk